Cocaine Trade Open in Canada? Not So Fast

In the U.S., cocaine is a Schedule II controlled substance and its use, possession, etc. is illegal except for certain, limited medical applications. The licensed sale of cocaine for recreational use is not even remotely a concept in the U.S., and the same goes for Canada. Why then did we see a Canadian cannabis company announce that it had the ability to make and sell cocaine to the consumer public? Essentially because of a mishap with or misunderstanding about a government license amendment it received from Health Canada. While not as “out there” as the premise of the popular movie Cocaine Bear, AdAstra’s announcement about being open for business in the commercialized cocaine market sent shockwaves through the cannabis and psychedelics industries.

Cocaine press release

On February 22, publicly traded (in Canada) AdAstra issued a press release in which it stated that its subsidiary, B.C. based AdAstra Labs, received approval from Health Canada “to include cocaine as a substance that the Company can legally possess, produce, sell and distribute”. The company claimed the same about psilocybin and psilocin. This alleged approval came in the form of an amendment to AdAstra Labs’ Controlled Drug and Substances Dealer’s License. After this announcement, the

The post Cocaine Trade Open in Canada? Not So Fast appeared first on GrowCola.com.

In the U.S., cocaine is a Schedule II controlled substance and its use, possession, etc. is illegal except for certain,… Continue reading
The post Cocaine Trade Open in Canada? Not So Fast appeared first on GrowCola.com. 

Leave a Reply

Your email address will not be published. Required fields are marked *

× Whatsapp